一名新西兰妇女自筹资金100 000美元,用于购买癌症药物Keyturda,敦促财政部长就拖延的公共供资采取行动。 A New Zealand woman self-funded $100,000 for cancer drug Keytruda, urging Finance Minister to act on delayed public funding.

一位54岁的奥克兰妇女凯瑟琳·库克(Catherine Cook)正在催促新西兰财政部长尼古拉·威利斯(Nicola Willis)在自筹资金10万美元后与她会面。 A 54-year-old Auckland woman, Catherine Cook, is pushing New Zealand’s Finance Minister Nicola Willis to meet her after self-funding $100,000 for Keytruda, a targeted cancer drug for early-stage triple-negative breast cancer not publicly funded in New Zealand despite availability in over 40 countries. Cook在2024年11月诊断后, 以700,000美元的损失出售了自己的生意, 以支付治疗费用, Diagnosed in November 2024, Cook sold her business at a $700,000 loss to afford treatment, highlighting the financial strain on patients when public funding is delayed. 她递交了17 000份签名请愿书,指出Keytruda是在新西兰投资名单的选项上,没有筹资时间表。 She presented a 17,000-signature petition, noting Keytruda is on New Zealand’s Options for Investment List without a funding timeline. 倡导者警告说,拖延获得诸如Keytruda和Kisqali等救生治疗,会增加长期保健和福利费用,敦促采取更快行动,预防晚期疾病和改善生存状况。 Advocates warn that delayed access to life-saving treatments like Keytruda and Kisqali increases long-term health and welfare costs, urging faster action to prevent advanced disease and improve survival.